CN104327009A - 一种阿瑞匹坦关键中间体的精制方法 - Google Patents
一种阿瑞匹坦关键中间体的精制方法 Download PDFInfo
- Publication number
- CN104327009A CN104327009A CN201410490598.7A CN201410490598A CN104327009A CN 104327009 A CN104327009 A CN 104327009A CN 201410490598 A CN201410490598 A CN 201410490598A CN 104327009 A CN104327009 A CN 104327009A
- Authority
- CN
- China
- Prior art keywords
- volume
- water
- purification according
- solution
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ATALOFNDEOCMKK-OITMNORJSA-N C[C@H](c1cc(C(F)(F)F)cc(C(F)(F)F)c1)O[C@H]1OCCN(CC(N2)=NNC2=O)[C@H]1c(cc1)ccc1F Chemical compound C[C@H](c1cc(C(F)(F)F)cc(C(F)(F)F)c1)O[C@H]1OCCN(CC(N2)=NNC2=O)[C@H]1c(cc1)ccc1F ATALOFNDEOCMKK-OITMNORJSA-N 0.000 description 1
- TYYTVELVKIRSMP-YKUJNDBESA-N C[C@H](c1cc(C(F)(F)F)cc(C(F)(F)F)c1)O[C@H]1OCCN(Cc2ccccc2)C1(c(cc1)ccc1F)O Chemical compound C[C@H](c1cc(C(F)(F)F)cc(C(F)(F)F)c1)O[C@H]1OCCN(Cc2ccccc2)C1(c(cc1)ccc1F)O TYYTVELVKIRSMP-YKUJNDBESA-N 0.000 description 1
- KVPJNHLVRGUYGQ-BFUOFWGJSA-N C[C@H](c1cc(C(F)(F)F)cc(C(F)(F)F)c1)O[C@H]1OCCN(Cc2ccccc2)C1=O Chemical compound C[C@H](c1cc(C(F)(F)F)cc(C(F)(F)F)c1)O[C@H]1OCCN(Cc2ccccc2)C1=O KVPJNHLVRGUYGQ-BFUOFWGJSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
时间(min) | 流动相A(%) | 流动相B(%) |
0 | 35 | 65 |
20 | 10 | 90 |
28 | 10 | 90 |
29 | 35 | 65 |
30 | 35 | 65 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410490598.7A CN104327009B (zh) | 2014-09-24 | 2014-09-24 | 一种阿瑞匹坦关键中间体的精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410490598.7A CN104327009B (zh) | 2014-09-24 | 2014-09-24 | 一种阿瑞匹坦关键中间体的精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104327009A true CN104327009A (zh) | 2015-02-04 |
CN104327009B CN104327009B (zh) | 2016-07-20 |
Family
ID=52401829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410490598.7A Active CN104327009B (zh) | 2014-09-24 | 2014-09-24 | 一种阿瑞匹坦关键中间体的精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104327009B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107894470A (zh) * | 2017-11-07 | 2018-04-10 | 中山奕安泰医药科技有限公司 | 一种阿瑞匹坦中间体的检测方法 |
CN107991406A (zh) * | 2017-11-24 | 2018-05-04 | 中山奕安泰医药科技有限公司 | 一种阿瑞吡坦中间体的检测方法 |
CN112485355A (zh) * | 2020-12-04 | 2021-03-12 | 中山奕安泰医药科技有限公司 | 一种3-氯甲基-1,2,4-三唑啉-5-酮纯度的检测方法 |
CN112666279A (zh) * | 2020-12-04 | 2021-04-16 | 中山奕安泰医药科技有限公司 | 一种阿瑞匹坦中间体纯度及其杂质的检测方法 |
CN112939885A (zh) * | 2021-02-05 | 2021-06-11 | 海南鑫开源医药科技有限公司 | 一种阿瑞吡坦关键中间体的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020052493A1 (en) * | 2000-06-08 | 2002-05-02 | Brands Karel M. Jos | Process for the synthesis of (2R, 2-alpha-R) -4-benzyl-2-[1- (3,5-bis (trifluoromethyl) phenyl) ethoxy] -1,4-oxazine-3-one |
CN1436178A (zh) * | 2000-06-08 | 2003-08-13 | 麦克公司 | (2R,2-α-R,3a)-2-[1-(3,5-双(三氟甲基)苯基)乙氧基]-3-(4-氟苯基)-1,4-噁嗪的合成方法 |
CN103788082A (zh) * | 2012-10-30 | 2014-05-14 | 天津卡普希科技有限公司 | 阿瑞匹坦ⅲ晶型物的制备方法 |
-
2014
- 2014-09-24 CN CN201410490598.7A patent/CN104327009B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020052493A1 (en) * | 2000-06-08 | 2002-05-02 | Brands Karel M. Jos | Process for the synthesis of (2R, 2-alpha-R) -4-benzyl-2-[1- (3,5-bis (trifluoromethyl) phenyl) ethoxy] -1,4-oxazine-3-one |
CN1436178A (zh) * | 2000-06-08 | 2003-08-13 | 麦克公司 | (2R,2-α-R,3a)-2-[1-(3,5-双(三氟甲基)苯基)乙氧基]-3-(4-氟苯基)-1,4-噁嗪的合成方法 |
CN103788082A (zh) * | 2012-10-30 | 2014-05-14 | 天津卡普希科技有限公司 | 阿瑞匹坦ⅲ晶型物的制备方法 |
Non-Patent Citations (4)
Title |
---|
KAREL M. J. BRANDS,等: "Efficient Synthesis of NK1 Receptor Antagonist Aprepitant Using a Crystallization-Induced Diastereoselective Transformation", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 * |
KAREL M. J. BRANDS,等: "Understanding the Origin of Unusual Stepwise Hydrogenation Kinetics in the Synthesis of the 3-(4-Fluorophenyl)morpholine Moiety of NK1 Receptor Antagonist Aprepitant", 《ORGANIC PROCESS RESEARCH & DEVELOPMENT》 * |
刘崇皓 等: "(2R,3S)-2-[(R)-1-[3,5-二(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)吗啉盐酸盐的合成", 《中国医药工业杂志》 * |
童庭敏 等: "新型化疗止吐药物阿瑞吡坦的制备研究进展", 《浙江化工》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107894470A (zh) * | 2017-11-07 | 2018-04-10 | 中山奕安泰医药科技有限公司 | 一种阿瑞匹坦中间体的检测方法 |
CN107991406A (zh) * | 2017-11-24 | 2018-05-04 | 中山奕安泰医药科技有限公司 | 一种阿瑞吡坦中间体的检测方法 |
CN112485355A (zh) * | 2020-12-04 | 2021-03-12 | 中山奕安泰医药科技有限公司 | 一种3-氯甲基-1,2,4-三唑啉-5-酮纯度的检测方法 |
CN112666279A (zh) * | 2020-12-04 | 2021-04-16 | 中山奕安泰医药科技有限公司 | 一种阿瑞匹坦中间体纯度及其杂质的检测方法 |
CN112666279B (zh) * | 2020-12-04 | 2022-05-20 | 中山奕安泰医药科技有限公司 | 一种阿瑞匹坦中间体纯度及其杂质的检测方法 |
CN112939885A (zh) * | 2021-02-05 | 2021-06-11 | 海南鑫开源医药科技有限公司 | 一种阿瑞吡坦关键中间体的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104327009B (zh) | 2016-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104327009A (zh) | 一种阿瑞匹坦关键中间体的精制方法 | |
TWI706939B (zh) | 新穎二取代1,2,4-三化合物 | |
CN105418603A (zh) | 一种高纯度帕布昔利布及其反应中间体的制备方法 | |
CN102026992A (zh) | 新的hsp90抑制性咔唑衍生物和含有该咔唑衍生物的组合物及其用途 | |
Balalaie et al. | Designing a sequential Ugi/Ullmann type reaction for the synthesis of indolo [1, 2-a] quinoxalinones catalyzed by CuI/L-proline | |
Busto et al. | Optically active macrocyclic hexaazapyridinophanes decorated at the periphery: synthesis and applications in the NMR enantiodiscrimination of carboxylic acids | |
Chambers et al. | Intramolecular 1, 3-dipolar cycloaddition as a route to triazolobenzodiazepines and pyrrolobenzodiazepines | |
CN107089981A (zh) | 一种BCL‑2抑制剂Venetoclax的合成方法 | |
CN103755628B (zh) | 2-氨基-3-碘-5-溴吡啶的合成方法 | |
CN101973981A (zh) | 一种1-(5-异喹啉磺酰基)高哌嗪盐酸盐的精制方法 | |
CN104725322A (zh) | 一种2-胺基嘧啶类化合物及其制备方法 | |
CN105732619B (zh) | 一种5,6,7,8‑四氢吡啶并[2,3‑d]嘧啶类化合物的合成方法 | |
Victoria | Dual catalytic enantioselective desymmetrization of allene-tethered cyclohexanones | |
Du et al. | Transition-Metal-Free, Intermolecular Azidoheteroarylation of Alkenes: Efficient Access to β-Azidoalkylated Quinoxalinones and Preliminary Antifungal Evaluation Against Magnaporthe grisea | |
CN102351847A (zh) | 一种工业化的埃索美拉唑钠盐的精制方法 | |
Schmidlehner et al. | Microwave-assisted synthesis of N-heterocycle-based organometallics | |
Melikyan et al. | Inter-and intramolecular isocarbon couplings of cobalt-complexed propargyl radicals: challenging the consensus | |
CN104193643B (zh) | 用于合成抗艾滋病药物增强剂cobicistat的中间体 | |
CN104045643B (zh) | 一种铜催化水相制备吡唑并[1,5-c]喹唑啉骨架化合物的方法 | |
CN106045914A (zh) | 一种三取代咪唑类化合物的合成方法 | |
Desai et al. | Development of a scalable palladium-catalyzed α-arylation process for the synthesis of a CGRP antagonist | |
CN110156672B (zh) | 一种氨基脲化合物制备方法以及制得化合物的应用 | |
JP2022520629A (ja) | 固体形態のfgfr阻害剤化合物およびその製造方法 | |
CN104974217B (zh) | 一类脱氢枞酸喹喔啉衍生物及其制备方法和应用 | |
CN105153167A (zh) | 一种替格瑞洛结晶及含有该结晶的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 989 250101 Applicant after: SHANDONG PROVINCE BIOMEDICAL ACADEMY OF SCIENCES Address before: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 989 250101 Applicant before: Pharmaceutical Sciences, Shandong Province |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: PHARMACEUTICAL SCIENCES, SHANDONG PROVINCE TO: SHANDONG PROVINCE BIOMEDICAL ACADEMY OF SCIENCES |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191216 Address after: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 989 250101 Patentee after: Pharmaceutical Sciences, Shandong Province Address before: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 989 250101 Patentee before: SHANDONG PROVINCE BIOMEDICAL ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right |